This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility assessed by patient/family interest
Timeframe: Baseline
Feasibility assessed by EndeavorRx training adherence rates
Timeframe: After completion of 4 weeks of EndeavorRx training
Feasibility assessed by reports of technical ease-of-use and satisfaction
Timeframe: End of training (+4 weeks)